Study Title: Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
 

• Status: Completed

• Participating Sites:
  • Holden Comprehensive Cancer Center, University of Iowa
  • Penn State Cancer Institute
  • University of Wisconsin Carbone Cancer Center
  • Froedtert and the Medical College of Wisconsin
  • Montefiore Medical Center
  • Methodist Hospital (Omaha, Neb.)
• Learn more:
  • clinicaltrials.gov: NCT02891161
  • Big Ten CRC News Release
• Publications and Presentations:
  • Rapid Abstract Session: 2021 Genitourinary Cancers Symposium
    See related coverage: ASCO Post
  • Oral Scientific Session: ASTRO 2020 Annual Meeting
  • Poster Session: 2020 Genitourinary Cancers Symposium

Study Contact: studies@hoosiercancer.org; (317) 921-2050.